- Datum09.06.2025
- Uhrzeit19:00 - 20:00 Uhr
- Veranstalter
BNP Paribas
Soligenix Inc. Aktie
Verkaufen
Kaufen
Soligenix Inc. Chart
Soligenix Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
4,89 %
Intraday
2,12 %
1 Woche
-2,03 %
1 Monat
-28,39 %
Seit Jahresbeginn
-48,94 %
1 Jahr
-98,49 %
3 Jahre
-99,62 %
5 Jahre
-99,45 %
10 Jahre
Passender Service zu Soligenix Inc.
Webinar zu Soligenix Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,680-14,830
- Jahrestief / Hoch ($)1,680-3,683
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Soligenix Inc.
Keine Dividenden verfügbar
Termine von Soligenix Inc.
Keine aktuellen Termine
Beschreibung
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
